Mesoblast (MESO) has released an update.
Mesoblast Limited has disclosed a change in the interests of Director Dr. Eric Rose, reporting an acquisition of 19,734 American Depositary Shares (ADSs) on-market, valued at US$151,207.83. The transaction has increased Dr. Rose’s indirect holdings to 41,162 ADSs, excluding the potential issue of additional ordinary shares pending shareholder approval at the upcoming Annual General Meeting.
For further insights into MESO stock, check out TipRanks’ Stock Analysis page.
